PCR amplification reactions PCR amplification of the TG microsatellite in the DRD2 locus was performed using the primers 509 and 419 (Hauge et al., 1993) and produced a four-allele polymorphism with bands of 80, 82, 84 or 86 bp in size. In a total volume of 10 il, 50 ng of genomic template DNA was amplified with 0.5 gIM primers, 1.5 mM magnesium chloride (Promega), 1 x PCR buffer (Promega), 200gtM dTTP, dGTP, dCTP, 0.5 units of Taq polymerase (Promega), and 0.1 L of [35SIdATP (12.5 mCi, Amersham). Amplification reactions were carried out in an ITCIOO thermal cycler (Bartelt Industries, Melbourne, Australia) as follows. An initial 4 min denaturation at 94°C was followed by 25 cycles of 40 s at 94C, 30 s at 56°C and 20 s at 74°C, with a 3 min final extension at 74C. PCR products were electrophoresed on a 5% polyacrylamide gel for 2 h. The gels were fixed, dried, then exposed to either Kodak X-OMAT film or a phosphor screen. This screen was scanned by the phosphorimager (Molecular Dynamics) after a 6-12 h exposure, and the autoradiographs were scanned by a densitometer (Molecular Dynamics) after a 24 h exposure. Resultant images were analysed using the computer software ImageQuant.
Su_numy We have examined a series of human colorectal adenomas, carcinomas and cell lines derived from human colorectal cancer for loss of heterozygosity (LOH) on chromosome lq22-23 by polymerase chain reaction (PCR) amplification of a microsatellite polymorphism of the dopamine D2 receptor (DRD2) locus. LOH was demonstrated in 5 30 (16.7%) adenomas and 23/68 (33.8%) carcinomas. Only 2,'20 (10%) cell lines showed homozygosity which could potentially be as a consequence of LOH. This moderate level of loss in the tumour samples was probably not an underestimation as a result of excessive stromal contamination because high rates (68-77%) have been detected in the same samples on chromosomes 17 and 18. In contrast to a previous report. LOH in carcinomas at 1I q22-23 occurred at a lower frequency and was not associated with Dukes' stage, degree of differentiation, mucin production or the location of the cancer. However, a significant association was found between LOH on chromosome 11 and chromosome 14. Thus, inactivation of any putative tumour-suppressor gene at lq22-23 by LOH is not a very common event in the development of colorectal tumours. but may be biologically significant if accompanied by chromosome 14 deletions.
Colorectal carcinogenesis is a multistep process involving both the activation of proto-oncogenes and the inactivation of tumour-suppressor genes. The current model originally described by Fearon and Vogelstein (1990) identifies four main mutations, which include ras oncogene point mutations and allelic deletions and point mutations of the tumoursuppressor genes APC, p53 and DCC on chromosomes 5, 17 and 18 respectively. However, some adenomas have been identified which contain all four of these mutations but have not progressed to carcinoma, suggesting that additional genetic events are necessary for the transition from adenoma to carcinoma. In addition, frequent LOH has also been reported in colorectal tumours on chromosome 8 (Fujiwara et al., 1993 ) and 14 (Young et al., 1993) .
Tumour-suppressor genes usually function in a recessive manner and therefore require both copies to be inactivated for tumour progression to occur (Knudson et al., 1971) . Loss of an allele is a common mechanism of inactivation, and hence detection of LOH is an important tool in identifying regions of the genome which may contain a tumour-suppressor gene. Chromosome 11 was considered a candidate for harbouring a tumour-suppressor gene because of cytogenetic analyses on colorectal cancers which have found frequent deletions in the long arm of chromosome 11 (Muleris et al., 1990; Konstantinova et al., 1991 The following cell lines were used in this study: HT-29, CaCo-2, Lisp-i, SW480, SW620, LIM1215, LIM1863, LIM2405, LIM2412, LIM1899, LIM2099, HCT-116, T84, LS174-T, KM12-SM, LS1034, LS41 IN, SW116, LS513 and LoVo. Cell lines were cultured in RPMI-1640 medium or Dulbecco's modified Eagle medium (Gibco), supplemented with 10% fetal calf serum. DNA extraction from both patient material and cell lines was essentially as described by Miller et al. (1988) .
PCR amplification reactions PCR amplification of the TG microsatellite in the DRD2 locus was performed using the primers 509 and 419 (Hauge et al., 1993) and produced a four-allele polymorphism with bands of 80, 82, 84 or 86 bp in size. In a total volume of 10 il, 50 ng of genomic template DNA was amplified with 0.5 gIM primers, 1.5 mM magnesium chloride (Promega), 1 x PCR buffer (Promega), 200gtM dTTP, dGTP, dCTP, 0.5 units of Taq polymerase (Promega), and 0.1 L of [35SIdATP (12.5 mCi, Amersham) . Amplification reactions were carried out in an ITCIOO thermal cycler (Bartelt Industries, Melbourne, Australia) as follows. An initial 4 min denaturation at 94°C was followed by 25 cycles of 40 s at 94C, 30 s at 56°C and 20 s at 74°C, with a 3 min final extension at 74C. PCR products were electrophoresed on a 5% polyacrylamide gel for 2 h. The gels were fixed, dried, then exposed to either Kodak X-OMAT film or a phosphor screen. This screen was scanned by the phosphorimager (Molecular Dynamics) after a 6-12 h exposure, and the autoradiographs were scanned by a densitometer (Molecular Dynamics) after a 24 h exposure. Resultant images were analysed using the computer software ImageQuant.
Analysis of LOH
Analysis of informative cases for LOH was accomplished by quantitating the density of bands produced by [35S]dATP incorporation during PCR amplification. LOH was calculated by a modification of the method by Solomon et al. (1987) , in which a ratio of allelic imbalance of less than 0.75 or greater than 1.25 was considered to show LOH. Analysis of 2 x 2 tables was carried out using a two-tailed Fisher exact test, and trend analysis performed by the Wilcoxon's rank-sum test. The Mantel-Haenszel inference was used to stratify for stage. Vogelstein et al. (1989) found LOH at the DllS144 locus at 1 lq22.3-23.3 in only 15% of tumours. Moreover, of 20 colorectal cell lines examined in this study only 10% were homozygous at this locus. Even if this was not due to natural homozygosity and had occurred through deletion of a second copy of a gene, 10% is a very low rate of LOH. These low rates of 10-33.8% LOH are somewhat inconsistent with those recently reported by Keldysh et al. (1993) , who observed cytogenetic deletions or LOH at 1 lq in 23/39 (59%) of tumours. There are at least two possible explanations for the lower incidence of LOH in our study. Firstly, we examined a larger sample consisting of 101 informative cases instead of 39, and so the lower frequency that we report is probably more accurate. Secondly, our sample population was chosen completely randomly, with no enrichment of the sample population by prior knowledge of llq chromosomal aberrations, whereas the sample that Keldysh et al. used included some tumours which were known by cytogenetic (1988) .
The possibility that a tumour-suppressor gene inactivated in colorectal cancer exists on 1 1q cannot be discounted simply because of the moderately low LOH rate observed in this study. Tanaka et al. (1991) found that human colon carcinoma cells into which a normal copy of chromosome 11 had been transferred exhibited a reduced tumour growth rate compared with that seen in the parental cells, although tumorigenicity was not reversed. This suggests that there may be a gene on chromosome 11 which has some effect on the rate of cell growth. Our data indicate that inactivation of a gene at 1lq22-23 by LOH is not a very common event in the development of colorectal tumours but that it is significantly associated with LOH on chromosome 14. This indicates that chromosome 11 deletions may be important if they occur in combination with losses on chromosome 14.
